Two dealuminated HY zeolites were employed as catalysts
for the Friedel−Crafts reaction of
biphenyl with benzyl chloride in a slurry batch reactor, with solvents
cyclopentane, cyclohexane,
and methylcyclohexane, at temperature from 50 to 100 °C. Mainly
benzylbiphenyl isomers (M),
but also appreciable quantities of dibenzyl derivatives (D) were
obtained and determined. Within
the monobenzylated fraction, a para-selectivity of 65−70%
at 60% conversion was reached.
Magnetic stirring was found to be adequate for a chemically
controlled reaction kinetics. Kinetic
models, including equations for the process itself and for the catalyst
deactivation, and applied
on the basis of optimization procedures, were used to correlate the
results. The model of choice
was able to interpret runs carried out at different doses of catalyst
and different initial
concentrations of the benzylating agent. A solvent effect on the
kinetics was evidenced.
Deactivated catalysts were regenerated for a few
reaction−regeneration cycles.
The liquid-phase alkylation of aromatics has been effected traditionally with catalysis by inorganic acids or AlCl 3 and similar compounds. However the increasing importance of solid acid catalysts is changing the procedures in this field. One of the prerequisites for the development of relevant processes, and the design of reactors, is knowledge of the kinetic data in reactions catalyzed by solid acids. This review examines the information available on the kinetics of alkylations catalyzed by solid acids, mainly zeolites, supported metal chlorides and oxides, mesoporous (MCM) materials, and heteropolyacids, but also other less studied materials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.